Amesite Inc. Reports Revenue Growth but Continues to Incur Losses in Latest 10-Q Filing

Amesite Inc. reported significant financial developments in its latest 10-Q filing for the quarter ending December 31, 2025. The company generated net revenue of $108,050 for the three months ended December 31, 2025, a substantial increase from $12,760 in the same period the previous year. For the six months ending December 31, 2025, revenue reached $202,346, compared to $24,010 for the same period in 2024. Despite this growth in revenue, Amesite continued to incur losses, reporting a net loss of $732,548 for the quarter and $1,374,814 for the six-month period, although these figures represent a decrease from losses of $1,121,637 and $2,029,682, respectively, in the prior year.

The company’s financial position has seen notable changes, with total assets decreasing to $1,997,983 as of December 31, 2025, down from $3,097,099 at the end of the previous fiscal year. This decline was primarily driven by a reduction in cash and cash equivalents, which fell to $1,165,369 from $2,333,418. Current liabilities also increased, totaling $489,790 compared to $358,596 in June 2025, largely due to a rise in accrued compensation. The accumulated deficit grew to $42,825,401, reflecting ongoing operational challenges.

Strategically, Amesite has pivoted its focus towards the healthcare sector, particularly with the launch of its NurseMagic™ app, which aims to streamline nursing documentation and enhance patient communication. This shift is part of a broader strategy to develop AI-driven solutions that cater to immediate market needs, moving away from previous efforts to secure academic customers. The company has also reported a decrease in general and administrative expenses, which fell to approximately $1,126,000 for the six months ended December 31, 2025, down from $1,438,000 in the prior year, attributed to reduced staffing and operational efficiencies.

Operationally, Amesite has made strides in expanding its customer base, with a notable reduction in reliance on a single customer, which accounted for only 11% of revenues in the latest quarter, compared to 90% in the same period last year. The company has also focused on reducing cash burn, which has been a significant concern given its history of net losses and negative cash flows. As of December 31, 2025, Amesite's cash, cash equivalents, and restricted cash totaled $1,265,369, indicating a need for continued financial management to support ongoing operations.

Looking ahead, Amesite's management has expressed uncertainty regarding its ability to maintain operations without additional financing, as it continues to face challenges in achieving profitability. The company has submitted a compliance plan to Nasdaq following a deficiency letter regarding its stockholders' equity, and it is actively exploring financing options to bolster its financial position. The outlook remains cautious, with management acknowledging the risks associated with its growth strategy and the need for sustained revenue generation to support future operations.